NCT06293898
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06293898
Title Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors SystImmune Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama Birmingham RECRUITING Birmingham Alabama 35294 United States Details
City of Hope RECRUITING Duarte California 91010 United States Details
Cedars Sinai RECRUITING Los Angeles California 90211 United States Details
University of Miami RECRUITING Miami Florida 33136 United States Details
Sarah Cannon Research institute - Lake Nona Florida RECRUITING Orlando Florida 32827 United States Details
Georgia Cancer Center at Augusta University RECRUITING Augusta Georgia 30912 United States Details
University of Illinois Cancer Center RECRUITING Chicago Illinois 60612 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Karmanos Cancer Institiute RECRUITING Detroit Michigan 48201 United States Details
NYU Langone Hospital - Long Island Investigational Pharmacy RECRUITING Mineola New York 11501 United States Details
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health RECRUITING New York New York 10016 United States Details
Sarah Cannon Research Institute RECRUITING Nashville Tennessee 37203 United States Details
Oncology Consultants RECRUITING Houston Texas 77030 United States Details
Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field